Get the latest research to your inbox
- The side effects of the chemotherapy have been reduced by an anti-inflammatory drug.
- In the world’s largest study of genetic factors in peptic ulcer disease, a link has been confirmed between depression and stomach ulcers.
- IMB researchers are sharing their expertise in tackling drug-resistant bacteria with low and middle income countries, thanks to new funding from CARB-X.
- Australians are being asked to help unravel the mysteries of COVID-19.
- IMB researchers are carrying out genome sequencing to provide clues as to why jellyfish venoms are so deadly.
- Venom from spitting cobras has evolved as a form of self-defence, rather than for capturing prey, and is more effective at causing pain than venom from non-spitters.
- The main non-psychoactive component of cannabis has been shown to kill the bacteria responsible for gonorrhoea, meningitis and Legionnaires' disease.
- Tackling antibiotic resistance and exploring the role of genomics in the novel coronavirus are the focus of new funding from the NHMRC, to fight infectious disease.
- A future making breakthroughs in inflammation research and sharing knowledge with the next generation of scientists at UQ are the targets for newly minted PhD Amy Chan.
Pages
Strawberry DNA extraction activity
Extract and view DNA from a strawberry using common household ingredients.
Get started
The Edge: Infection
The latest research and discovery
We are tackling the problem of drug-resistant bacteria through developing new diagnostics and treatments, and by empowering the community with knowledge on how to fight back against the threat of superbugs.
Subscribe to our newsletter
Get the latest research straight to your inbox.
Stay up-to-date as we answer questions about hot topics, and share the latest news at IMB, Australia’s #1 research institute.
General enquiries
+61 7 3346 2222
imb@imb.uq.edu.au
Media enquiries
IMB fully supports UQ's Reconciliation Action Plan and is implementing actions within our institute.
Support us
Donate to research
100% of donations go to the cause